Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cenra Inc., formerly known as China Chemical & Pharmaceutical Co., Ltd. (CCPC), is a leading vertically integrated pharmaceutical and healthcare group based in Taiwan. Founded in 1952, the company has evolved from a generic drug manufacturer into a diversified healthcare platform with operations spanning active pharmaceutical ingredients (APIs), human and animal pharmaceuticals, consumer health products, and senior care services. Cenra operates multiple PIC/S GMP-certified manufacturing sites and maintains a strong presence in Taiwan and mainland China. The company's strategic focus includes the development of complex generics and 505(b)(2) new drug applications for global markets, supported by partnerships with international firms such as Moderna, Dr. Reddy's, and Ono Pharmaceutical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CCPC.